2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models

Publication date

2025-05-21

Authors

Di Angelantonio, Emanuele
Pennells, Lisa
Abdelhamid, Magdy
Aboyans, Victor
Asteggiano, Riccardo
Čelutkienė, Jelena
Grobbee, RickORCID 0000-0003-4472-4468ISNI 0000000030206553
Iung, Bernard
Jüni, Peter
McEvoy, John William

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

The level of evidence (LOE) grading system for European Society of Cardiology (ESC) Clinical Practice Guidelines (CPG) classifies the quality of the evidence supporting a recommendation. However, the current taxonomy does not fully consider the optimal study design necessary to establish evidence for different types of recommendations in ESC guidelines. Therefore, two separate task forces of clinical and methodological experts were appointed by the CPG Committee, with the first tasked with updating the LOE grading system for therapy and prevention and the second responsible for developing a LOE grading system for diagnosis and prediction. This report from the second of these Task Forces develops a new system for diagnostic tests and prediction models which maintains the three-level grading structure to classify the quality of the evidence but introduces new definitions specific for diagnosis and prediction. For diagnostic tests, LOE A represents conclusive evidence of adequate diagnostic ability from at least two high-quality studies. Level of evidence B represents suggestive evidence from one high-quality or at least two moderate-quality studies. Level of evidence C represents preliminary evidence not classified as A or B, including evidence from less than two moderate-quality studies, or from expert consensus. For prediction models, LOE A represents conclusive evidence of adequate predictive ability from at least one high-quality derivation and two or more external validation studies of at least moderate quality. Level of evidence B represents suggestive evidence in one or more derivation studies and one or more external validation studies of at least moderate quality. Level of evidence C represents preliminary evidence not classified as A or B, including evidence from a derivation study of at least moderate quality, but with low quality or no external validation, or a derivation study of low quality.

Keywords

Cardiovascular disease, Clinical Practice Guidelines, Diagnostic ability, Diagnostic tests, European Society of Cardiology, Evidence grading, Prediction models, Predictive ability, Study quality, Taverne, Cardiology and Cardiovascular Medicine, Journal Article

Citation

Di Angelantonio, E, Pennells, L, Abdelhamid, M, Aboyans, V, Asteggiano, R, Čelutkienė, J, Grobbee, D E, Iung, B, Jüni, P, McEvoy, J W, Rakisheva, A, Rossello, X, Visseren, F L J, Baigent, C & Prescott, E B 2025, '2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II : diagnostic tests and prediction models', European heart journal, vol. 46, no. 20, ehaf016, pp. 1895-1906. https://doi.org/10.1093/eurheartj/ehaf016